Doug Ball named interim president at Pittsburg State University
PITTSBURG, Kan. — Pittsburg State will soon have a new leader, at least temporarily.
Last week, the Kansas Board of Regents announced that Chief Financial Officer/Vice President for Administration Doug Ball will be the university's interim president.
Ball will fill the spot currently held by DR. Dan Shipp, who is leaving at the end of May to become the next president of Maryville University in St Louis. Ball has served in his current role at Pitt State since 2017 and earned his bachelor's degree in business administration from PSU.
A search committee is narrowing the field of applicants to find Pitt State's next president, but school leaders say that could take a while.
Doug Ball named interim president at Pittsburg State University
ROTC Commissioning Ceremony held at PSU
PSU nursing student overcomes barriers and achieves her dream
PSU students build dog houses to support foster-based rescue
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
4 hours ago
- Yahoo
Kentucky auditor reviewing concerns surrounding Fayette County Public Schools finances
LEXINGTON, Ky. (FOX 56) — State leaders said Fayette County parents are voicing concerns about financial decisions being made by school board leadership after an attempted tax hike was found unlawful by the attorney general's office. Kentucky AG: Fayette County Public Schools violated law in attempted tax hike According to Fayette County Public Schools (FCPS) leaders, an occupational tax increase was proposed as a necessary evolution in the school's future budget to balance against anticipated funding cuts, as well as increased demand on school staff and the school facilities themselves. 'This shift broadens the tax base to equitably support public education and ensure long-term sustainability without placing additional strain on property owners,' Dia Davidson-Smith, spokesperson for FCPS, said. 'We encourage our community to look beyond headlines and social media chatter and consider the full context of our decisions. Each investment is made thoughtfully, strategically, and with the success of our students in mind. Our progress is not by chance. It is the result of deliberate planning, partnership, collaboration, and a deep belief in the power of public education.' Kentucky Attorney General Russell Coleman wrote on Wednesday in an opinion that the school board's tax hike proposal was unlawful. HPD arrests woman for allegedly threatening drivers with box cutter Looking for a perfect swim day? These are the 5 clearest lakes in Kentucky Release of Steven Lawson proceedings temporarily prohibited by court 'If the Fayette County School Board members believe they need more of Kentuckians' hard-earned dollars, they should clearly and publicly make their case before their own constituents,' the attorney general wrote. Sen. Amanda Mays Bledsoe, R-Lexington, said in a news release on Thursday that she proposed the possibility of initiating an FCPS audit to State Auditor Allison Ball. She commended the Fayette County Fiscal Court for its decision to halt a vote on the proposed hike. Fayette County fiscal court halts vote on school tax increase after AG opinion 'Given widespread concerns about spending priorities and the recent tax controversy, an independent review could provide much-needed transparency and reassurance,' Bledsoe said in a news release. 'Taxpayers deserve to know that education dollars are being used effectively, and I will continue to push for accountability where it's needed.' Auditor Ball told FOX 56 that she's heard about financial concerns at FCPS from more sources than just Sen. Mays-Bledsoe. 'I have heard from parents and other constituents concerned about the state of FCPS,' Ball said. 'In light of our ongoing audits of the Kentucky Department of Education and the Jefferson County Public School system, my office is reviewing these concerns to determine our next steps.' The school board carried out the rest of its June 5 meeting as planned, deciding on unrelated agenda items. The next school board meeting will be June 23. Madylin Goins contributed to this story. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
San Francisco Chronicle
2 days ago
- San Francisco Chronicle
A new California winery will change your mind about Chardonnay
It's become fashionable in recent years to praise lean, laser-focused California Chardonnay — some would say 'Chablis-style' Chardonnay — as a rebuke to the overblown butter-and-oak bombs that proliferated beginning in the 1990s. But that line of thinking neglects to account for the full-bodied California Chardonnays that are made well — expertly, even. When a winemaker gets it right, there's nothing like it. A rich Chardonnay can be as luscious as uni melting on the tongue, as decadent as a smear of soft-ripened cheese, as satisfying as biting into a juicy, runny peach. A new Sonoma County winery, Sphaerics, makes a convincing argument for this style. It produces Chardonnay exclusively, and all three of its single-vineyard wines are rich and complex, with a tense line of acidity that keeps them in balance. Now, three years in, Sphaerics will expand its small production thanks to the purchase of its own Sonoma Coast vineyard. Since meeting as students at U.C. Davis, Laura Jones and Brian Ball had always wanted to start their own winery, said Ball, 'but only if we can make something really unbelievable.' The couple have each had varied careers in the wine industry and now both work at Skipstone Ranch in Alexander Valley; he's the general manager, she's the winemaker. They set their sights on Chardonnay, not only because it's what they love to drink but also because Jones loves making it. Jones spent five years as the assistant winemaker at Aubert Wines in Calistoga, arguably the benchmark producer of rich, creamy, indulgent California Chardonnay. (Conveniently, Skipstone's only white wine is a Viognier, so there's no competition with their employer.) Their opportunity arrived in 2022, when the Jackson family offered to sell them Chardonnay grapes from the Upper Barn Vineyard, one of Skipstone's neighbors in Alexander Valley. Upper Barn has a notable legacy with some of the most prestigious names of the rich-Chardonnay camp: Helen Turley made Upper Barn Chardonnay when she was the winemaker for Peter Michael Winery, where it became a bottling known as Mon Plaisir, 'my pleasure.' She also used Upper Barn grapes for her own label, Marcassin. Turley's protégé Mark Aubert later made the Upper Barn Chardonnay when he worked for Peter Michael. Now Aubert's protégé, Jones, would be the next steward of these grapes. 'It was like this mentor-to-protégé winemaker family tree,' Ball said. They call the Upper Barn Chardonnay 'If and Only If,' a reference to their condition for starting the winery in the first place. The 2023 vintage is very expressive, reminding me of marzipan, ginger and apricot. As creamy and full as it is, it has a persistent, refreshing brightness. 'I love really long fermentations,' said Jones. She ferments her Chardonnays in barrels using indigenous yeast, and they typically don't complete their secondary malolactic fermentations until the following spring. (Most wineries would have this wrapped up within a matter of weeks following harvest.) She doesn't filter or fine the wines, nor does she practice battonage — the stirring of lees while a wine is aging in barrel, which can add oomph and body — meaning the wine gets its richness primarily from its raw materials. 'I pick on the riper side,' said Jones. 'The grapes should taste delicious. They should taste good. Like candy.' This sounds like an almost direct refutation of winemaker Raj Parr 's anti-ripeness maxim, now famous in industry circles: 'If you pick a grape off the vine and it tastes yummy, you've already missed it.' The Upper Barn Chardonnay is Sphaerics' flagship, and its most expensive at $140. The rest of the lineup consists of Overline ($65), a lighter expression from Carneros that's reminiscent of tangy yogurt, yellow peach and basil; and On Days and Nights ($80), from the Russian River Valley, which has flavors of fennel, toasted hazelnut and Meyer lemon. These are bold prices for Chardonnay, in line with high-end producers like Aubert, Peter Michael and Kistler. This year, Ball and Jones will add red wine to the mix after acquiring their estate vineyard. Located near the town of Occidental, the site has 13 acres of Pinot Noir and Chardonnay. When the couple began scouting for properties, Ball pulled up Google Maps and asked Jones: 'Where in your dream would you want our vineyard to be?' She pointed to this particular area of the Sonoma Coast, where the fluffy Goldridge soils are known to be ideal for Burgundian grape varieties. Many of the wines that Jones had made at Aubert came from this area. When they saw a listing in that exact neighborhood that fit their budget, they felt that it was fate. They closed in May — and are legally prohibited from naming the vineyard's previous owner or which wineries bought its fruit. Coming up with a name for a winery that's not already trademarked is notoriously difficult, especially when 'your last names are not exciting,' said Jones. They chose Sphaerics, the title of the foundational text on the geometry of the sphere written by Theodosius of Bithynia in the 2nd or 1st century BC. It's partly a play on Ball's last name. It's also a nod to the shape of winemaking itself. 'Think of the most important objects that make wine,' Ball said: 'the shape of a grape, the shape of the earth, the shape of the moon.'
Associated Press
2 days ago
- Associated Press
Bullpen Launches Emerging Fund to Champion the Next Generation of Life Sciences Innovators
New investment initiative fuels high-potential startups across biotools, medtech, digital health, and therapeutics. 'BIO Week is our opportunity to strip away the noise and create a space where life science leaders can connect authentically, share candid insights, and forge the partnerships.'— Christiaan Engstrom, CEO of Bullpen. BOSTON, MA, UNITED STATES, June 4, 2025 / / -- Bullpen, a trusted community of life sciences dealmakers, today announced the launch of its Bullpen Emerging Fund, a bold initiative designed to back mission-driven startups that are redefining the future of health. Through capital investment, deep mentorship, and access to a close-knit network of expert operators and investors, the fund aims to turn today's early-stage breakthroughs into tomorrow's clinical realities. The Emerging Fund, available to accredited investors, invests in standout companies selected for Bullpen's On-Deck class—founders chosen not only for their science but for their grit, vision, and purpose. The 2025 cohort includes: - Chandima Bandaranayaka, CEO: Precision Quantomics, accelerating drug discovery and personalized pharmacotherapy through high-resolution molecular profiling. - David Mead, CEO: Terra Bioforge, harnessing synthetic biology to streamline biological production and accelerate therapeutic development. - Doug Cohen, CEO: IR Medtek, developing real-time, noninvasive cancer detection technologies that improve early diagnosis and patient outcomes. - Harsha Rajasimha, CEO: Jeeva Clinical Trials, delivering decentralized trial software that enhances patient access, retention, and diversity in clinical research. - Linda Tempelman, CEO: Persista Bio, advancing cell therapy solutions for chronic diseases, including a novel approach to treating Type 1 diabetes. Each of these founders will pitch during Bullpen's 'Money Ball' sessions, June 16–18 at BIO International, to an audience of mission-aligned investors and partners. More than a moment on stage, these pitches represent the culmination of rigorous preparation and the start of a meaningful growth journey. 'Bullpen was built on a simple idea: if you bring the right people together in the right way, the outcomes take care of themselves. BIO Week is our opportunity to strip away the noise and create a space where life science leaders can connect authentically, share candid insights, and forge the partnerships that will move this industry forward,' said Christiaan Engstrom, CEO of Bullpen. Further information on the Bullpen Emerging Fund may be obtained from Ray Jordan, managing director, Putnam Insights LLC, and initial investor in the fund through Elmstead Partners LLC. Jordan may be reached at [email protected]. Expert Coaching to Catalyze Success Behind each founder is a seasoned mentor: - Michael Hill, Global Head of Science Innovations, MedTech Head Coach, with a legacy of scaling clinical tools from bench to bedside. - Stella Vnook, CEO of Likarda and Therapies Head Coach, a biotech operator with deep experience in moving science-backed products through commercial launch. - John Bonham-Carter, BioTools Head Coach and angel investor, guiding early-stage science into successful enterprise with strategic insight and operational depth. Throughout the week, Bullpen will host engaging programming across Boston innovation hubs like Portal Innovations, SmartLabs, and EPAM Continuum. Key agenda highlights include: Agenda Highlights Include: - Investor interviews with leaders from Novo Nordisk, Cincytech, DigitalDx, Mayo Clinic, Riverside Partners, and others, with open Q&A in the Press Room following each session. - Thematic forums exploring pivotal industry issues such as: - AI in Healthcare: Exploring how artificial intelligence is reshaping patient care and discovery. - Patient Access: Breaking down barriers to get therapies to those who need them most. - Tech Transfer: Bridging academic science and commercial application. - Rare Disease: Elevating patient voices and rare innovation journeys. - Global Forums: Perspectives from Japan, Korea, Canada, and Australia spotlighting international innovation. - Women in VC and venture insights sessions, giving voice to underrepresented perspectives in capital formation and funding trends. As BIO Week wraps, Bullpen leaves behind more than a schedule, it strengthens a movement. One that champions science, centers people, and dares to do things differently. With the Emerging Fund as its catalyst, Bullpen is helping the next generation of health innovators go further, faster. About Bullpen: Founded on the mantra Find Someone to Help. Repeat., Bullpen is a volunteer-led, member-driven network designed to foster meaningful connections and accelerate innovation in life sciences. With no booths or sales pitches, Bullpen cultivates a space where authentic conversation drives real outcomes. Its members include public and private company leaders, VCs, strategics, accelerators, and non-profit executives dedicated to building the future of health. Media Inquiries: Madelyn De Los Santos Putnam Insights email us here Legal Disclaimer: EIN Presswire provides this news content 'as is' without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
